Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Mylan Completes Acquisition of Renaissance’s Leading Topicals-Focused Specialty and Generics Business

HERTFORDSHIRE, England and PITTSBURGH, June 15, 2016 /PRNewswire/ — Mylan N.V. (NASDAQ, TASE: MYL) today announced that it has successfully completed the acquisition of the non-sterile, topicals-focused specialty and generics business (the “Business”) of Renaissance Acquisition Holdings, LLC (“Renaissance”). The Business brings Mylan an attractive and complementary portfolio and pipeline of branded and generic topical […]

Read More »

Can coffee cause cancer? Only if it’s very hot, says WHO agency

There is no conclusive evidence that drinking coffee causes cancer, the World Health Organization’s cancer agency said in a reverse of its previous warning, but it also said all “very hot” drinks are probably carcinogenic.

Read More »

Chiasma Chops 33 Percent of Workforce

Chiasma Inc. is undergoing a drastic corporate restructuring in an effort to preserve capital for the continued development of its experimental acromegaly treatment Mycapssa.

Read More »

Drugmaker Aegerion Merges with QLT

After terminating 25 percent of its workforce two months ago, Aegerion Pharmaceuticals Inc. has entered into a merger agreement with QLT Inc.

Read More »

Second study this week links whole grains with long life

Bumping up whole grain intake even slightly may lower the risk of death from heart disease, cancer and other chronic diseases, according to a review published in The BMJ.

Read More »

WHO sees ‘very low’ risk of further Zika spread due to Olympics

There is a “very low risk” of further international spread of Zika virus as a result of the Olympic Games to be held in Brazil, the heart of the current outbreak linked to birth defects, World Health Organization (WHO) experts said.

Read More »

Senators introduce bill supporting generic drugs

Four U.S. senators introduced a bill aimed at preventing big pharmaceutical companies from using safety rules to prevent generic drugs from coming to market.

Read More »

Start school later to prevent sleep-deprived teens: U.S. doctors

The American Medical Association urged starting school later in the morning for teenagers so they can get enough sleep.

Read More »

Jardiance slows diabetics’ kidney disease progression

Eli Lilly and Co’s Jardiance diabetes drug slashed the risk of progressive kidney disease in adults with type 2 diabetes in a large trial.

Read More »

Once Floated as Allergan (AGN) Target, Revance (RVNC)’s Stock Drops as Crow’s Feet Drug Fails Trial

Newark, California-based Revance Therapeutics announced yesterday that its DaxibotulinumtoxinA Topical Gel (RT001) failed to meet its co-primary and other endpoints. RT001 was being tested to treat patients with moderate to severe lateral canthal lines, otherwise known as crow’s feet.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

April 2019 Focus: Healthcare agency & network profiles, industry overview & awards, and more!


Ad Right Bottom